BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32246818)

  • 1. Identification of an exosomal long non-coding RNAs panel for predicting recurrence risk in patients with colorectal cancer.
    Zhang Y; Liu H; Liu X; Guo Y; Wang Y; Dai Y; Zhuo J; Wu B; Wang H; Zhang X
    Aging (Albany NY); 2020 Apr; 12(7):6067-6088. PubMed ID: 32246818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Exosomal Long Non-Coding RNAs Serve as Biomarkers for Early Detection of Colorectal Cancer.
    Hu D; Zhan Y; Zhu K; Bai M; Han J; Si Y; Zhang H; Kong D
    Cell Physiol Biochem; 2018; 51(6):2704-2715. PubMed ID: 30562751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
    Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
    J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low level of exosomal long non-coding RNA
    Oehme F; Krahl S; Gyorffy B; Muessle B; Rao V; Greif H; Ziegler N; Lin K; Thepkaysone ML; Polster H; Tonn T; Schneider M; Weitz J; Baenke F; Kahlert C
    RNA Biol; 2019 Oct; 16(10):1339-1345. PubMed ID: 31251124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
    Matsumura T; Sugimachi K; Iinuma H; Takahashi Y; Kurashige J; Sawada G; Ueda M; Uchi R; Ueo H; Takano Y; Shinden Y; Eguchi H; Yamamoto H; Doki Y; Mori M; Ochiya T; Mimori K
    Br J Cancer; 2015 Jul; 113(2):275-81. PubMed ID: 26057451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
    Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer.
    Baassiri A; Nassar F; Mukherji D; Shamseddine A; Nasr R; Temraz S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
    Yang ZD; Kang H
    World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer.
    Wang R; Du L; Yang X; Jiang X; Duan W; Yan S; Xie Y; Zhu Y; Wang Q; Wang L; Yang Y; Wang C
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2291-301. PubMed ID: 27591862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
    Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
    Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer.
    Wang L; Duan W; Yan S; Xie Y; Wang C
    Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
    Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
    Li S; Zhang M; Zhang H; Hu K; Cai C; Wang J; Shi L; Ma P; Xu Y; Zheng P
    Clin Chim Acta; 2020 Feb; 501():252-257. PubMed ID: 31730812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.